biote Corp.

Total Valuation

biote Corp. carries a market capitalization of 108.50M, placing it among publicly traded companies globally. Its enterprise value stands at 153.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

biote Corp. currently has 29.99M shares outstanding.

Valuation Ratios

biote Corp. trades at a trailing price-to-earnings ratio of 2.69. The price-to-sales ratio is 0.22, and the price-to-book ratio stands at -0.91.

Enterprise Valuation

On an enterprise value basis, biote Corp. trades at an EV/EBITDA multiple of 4.67 and an EV/FCF ratio of 3.46. The EV/Sales ratio of 0.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.28 provides insight into valuation relative to core operating earnings.

Financial Position

biote Corp. maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -226.09, indicating conservative leverage, while an interest coverage ratio of 3.27 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, biote Corp. has paid 5.03M in income taxes, reflecting an effective tax rate of 21.45.

Stock Price Statistics

biote Corp.'s stock has declined approximately -38.19095% over the past 52 weeks. The 50-day moving average sits at 2.07, while the 200-day moving average is 2.41.

Income Statement

Over the trailing twelve months, biote Corp. generated 188.16M in revenue and converted that into 15.60M in net income, yielding earnings per share of 0.55. EBITDA reached 32.82M, while operating income came in at 29.03M.

Balance Sheet

biote Corp. holds 5.32M in cash and equivalents against 108.42M in total debt, resulting in a net debt position of 100.36M. Total book value stands at -46.03M, with working capital of 8.13M providing operational flexibility.

Cash Flow

biote Corp. produced 32.63M in operating cash flow over the past twelve months. After subtracting -3.75M in capital expenditures, free cash flow totaled 28.88M - equivalent to 0.93 per share.

Margins

biote Corp. operates with a gross margin of 70.12, reflecting its pricing power and cost economics. The operating margin of 15.43 and net profit margin of 8.29 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 6.76 indicates the proportion of earnings distributed to shareholders.

Scores

biote Corp. posts an Altman Z-Score of 3.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.